Agenus Inc (AGEN)
6.465
+0.70
(+12.05%)
USD |
NASDAQ |
Apr 23, 16:00
6.465
0.00 (0.00%)
After-Hours: 17:35
Agenus Market Cap: 135.42M for April 23, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 22, 2024 | 120.86M |
| April 19, 2024 | 111.22M |
| April 18, 2024 | 104.10M |
| April 17, 2024 | 113.11M |
| April 16, 2024 | 131.96M |
| April 15, 2024 | 136.15M |
| April 12, 2024 | 170.71M |
| April 11, 2024 | 185.79M |
| April 10, 2024 | 186.88M |
| April 09, 2024 | 203.80M |
| April 08, 2024 | 195.01M |
| April 05, 2024 | 211.01M |
| April 04, 2024 | 211.93M |
| April 03, 2024 | 222.07M |
| April 02, 2024 | 214.49M |
| April 01, 2024 | 246.12M |
| March 28, 2024 | 242.97M |
| March 27, 2024 | 233.09M |
| March 26, 2024 | 224.71M |
| March 25, 2024 | 233.92M |
| March 22, 2024 | 228.77M |
| March 21, 2024 | 235.52M |
| March 20, 2024 | 232.33M |
| March 19, 2024 | 235.68M |
| March 18, 2024 | 221.90M |
| Date | Value |
|---|---|
| March 15, 2024 | 226.22M |
| March 14, 2024 | 251.23M |
| March 13, 2024 | 275.90M |
| March 12, 2024 | 280.34M |
| March 11, 2024 | 282.10M |
| March 08, 2024 | 280.72M |
| March 07, 2024 | 280.04M |
| March 06, 2024 | 279.56M |
| March 05, 2024 | 268.46M |
| March 04, 2024 | 272.41M |
| March 01, 2024 | 263.62M |
| February 29, 2024 | 267.58M |
| February 28, 2024 | 300.01M |
| February 27, 2024 | 310.63M |
| February 26, 2024 | 289.74M |
| February 23, 2024 | 272.41M |
| February 22, 2024 | 269.57M |
| February 21, 2024 | 263.26M |
| February 20, 2024 | 266.86M |
| February 16, 2024 | 261.55M |
| February 15, 2024 | 261.03M |
| February 14, 2024 | 370.46M |
| February 13, 2024 | 303.47M |
| February 12, 2024 | 323.11M |
| February 09, 2024 | 298.68M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
104.10M
Minimum
Apr 18 2024
1.516B
Maximum
Aug 30 2021
617.50M
Average
598.04M
Median
Market Cap Benchmarks
| Protalix BioTherapeutics Inc | 88.03M |
| InfuSystems Holdings Inc | 169.69M |
| PAVmed Inc | 16.97M |
| Allogene Therapeutics Inc | 569.84M |
| Pfizer Inc | 148.62B |
Market Cap Related Metrics
| PS Ratio | 0.7396 |
| Price | 6.465 |
| Earnings Yield | -216.6% |